Cleo

Profile (continued)

FUNDING: Per Owler's funding breakdown (cross-checked against MobiHealthNews and PR Newswire for the Series B and Series C where possible), Cleo raised roughly $80.9M across four rounds: a ~$2.3M Seed round (March 2017, Forerunner Ventures and Felicis Ventures); an ~$11.2M Series A (June 2018) led by Greylock Partners -- this is the round Greylock's own site cites as when it 'first partnered' with Cleo; a $27.5M Series B (announced ~March 2019) led by New Enterprise Associates (NEA), independently confirmed via a MobiHealthNews digital-health funding brief; and a ~$40M Series C (March 2021) with investors including Transformation Capital, Greylock, and NEA. No funding round has been publicly reported since March 2021 as of this research (August 2026), though the company remains active and continues to publish research/marketing content. No current valuation was found in public sources.

LEADERSHIP: There is a notable discrepancy across sources on who currently serves as CEO. Sarahjane Sacchetti is documented as CEO in a November 2020 MobiHealthNews article ('Cleo preps for the future of employer family benefits with a new board member') and in an October 2022 PR Newswire release (Family Health Index launch), and is also listed as CEO on Greylock's own portfolio page and on Owler (both accessed August 2026, though Owler pages can be stale). However, the two most recent PR Newswire releases from Cleo -- April 2025 and February 2026 (the 2nd and 3rd annual Family Health Index reports) -- both explicitly quote 'Dr. Madhavi Vemireddy, CEO.' Given the recency of these two 2025/2026 releases relative to Greylock's page, this profile treats Madhavi Vemireddy as the current CEO, while flagging that Greylock's own portfolio page had not been updated to reflect this as of the research date. Vemireddy, an MD (MBBS, Sri Ramachandra Medical College; internal medicine residency at St. Luke's-Roosevelt) with prior roles at ActiveHealth and Aetna, co-founded CareTribe in 2018-2019 and joined Cleo (initially in a Chief Clinical Officer-type role, per TheOrg, though the CareTribe deal was announced in 2022) before apparently ascending to CEO by 2025. Other confirmed/former leadership includes Dr. Chitra Akileswaran (Co-Founder & CMO), Tyler Hoersch (CTO, ex-SVP Engineering at Virgin Pulse), and board director Karin Ajmani (appointed ~October 2020; public-health background from Columbia; prior CEO of CarePlus Health Plans and President/Chief Strategy Officer at Progyny). NEA partner Vanessa Larco was identified in the CareTribe acquisition release as an NEA partner and Cleo investor, suggesting a likely board or observer role, though this was not explicitly confirmed as a board seat.

CUSTOMERS & METRICS: Cleo has named eBay, LinkedIn, Uber, Straus Family Creamery, Pinterest, Reddit, and Box as employer clients across different sources/time periods. A November 2020 article cited 'over 640,000 users from [Cleo's] four largest employers.' An October 2022 release cited '130+' employer clients and a study finding Cleo members were 30% less likely to plan on leaving their jobs than non-Cleo working parents/caregivers. FHI-based releases cite 12,500+ assessments (April 2025) growing to 19,200+ (February 2026). Employee-count estimates vary by source: TheOrg lists 51-200; Owler lists 100-250 with estimated annual revenue of $5.0-25M.

COMPETITIVE LANDSCAPE: Owler lists Cleo's competitors as including Maven Clinic, Ovia Health, Stork Club, BabyCenter, My Family Care, and several international parenting apps (Yaolan, BabyChakra, Tinystep, LUCY, Babytree); other commonly cited competitors in the family-benefits/caregiving-benefits space (e.g., Wellthy, Cariloop, Kindbody) were not independently confirmed via a cited source in this research and are therefore omitted.

Go-to-market

Large and mid-size employers and health plans seeking to offer family-care and caregiving benefits to their workforce; end users are working parents and caregivers (childcare through elder/adult caregiving).

Ownership

private